FTSE 100 pharma giants GSK and Astrazeneca appear to swerve Trump tariffs
Thursday, 3 April 2025 () FTSE 100 pharma giants GSK and Astrazeneca may have escaped the worst of US President Donald Trump’s tariffs, according to a City broker. Pharmaceutical goods appear to be exempt from higher-rate tariffs introduced by President Trump in his Rose Garden ‘Liberation Day’ address on Wednesday, but there is still uncertainty about the impact on the [...]
President Donald Trump has unleashed sweeping new "Liberation Day" tariffs, imposing a minimum 10% baseline on trading partners, including Mexico. As tensions rise, Mexican President Claudia Sheinbaum has ruled out immediate retaliatory tariffs, instead focusing on a strategic economic defense plan....
Donald Trump shocks the world with what he calls "reciprocal tariffs" on almost all US trading partners around the world. Will these new tariffs be a boom or a bust for the US..
The UK Government says it is considering “possible retaliatory action” after US President Donald Trump announced a 10% tax on British goods imported to the US, on top of previously announced..
Did pharma sector dodge Trump’s tariffs? The EU's not so sure
The fear of a trade war over pharmaceuticals between the EU and the US has been avoided for now, but the European Commission remains..
Credit: euronews (in English) Duration: 02:08Published